Effect of Vit D therapy on anti-Mullerian hormone (AMH) level in women with infertility
Not Applicable
- Conditions
- Infertility.Female infertility associated with anovulation
- Registration Number
- IRCT201604137917N2
- Lead Sponsor
- Vice chancellor for research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Inclusion criteria : patients suffering infertility with insufficient Vit. D (lower than 30 ng/ml); Anti mullerian horman level less than 0.7 ng/ml.
Exclusion criteria :Vit Duse contraindication; Vit D use during 4 months before study; use of OCP during 2 months before study; thyroid function disorder; hyper prolactinemia; diabetes melituse; cogenital adrenal hyperplasia; Use of drugs affect on adrenal and ovarian function and metabolism of carbohydrates and lipids; Pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti Mullerian Hormone Level. Timepoint: before and three months after intervention. Method of measurement: Hospital Labratoary.
- Secondary Outcome Measures
Name Time Method Fertility. Timepoint: up to one year after intervention. Method of measurement: Birth Report of the participants.